Clinical Trial Update: Phase 2 Study to Evaluate the Microbiology and Safety of C16G2 Administered to Adult and Adolescent Dental Subjects [Phase 2]

View source ↗

Summary

Phase 2 study evaluating microbiology and safety of C16G2 in adults and adolescents with dental caries has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dental Caries

Drugs mentioned

• C16G2

Snippet

Sponsor: Armata Pharmaceuticals, Inc. | Conditions: Dental Caries | Phase 2 | Status: COMPLETED